Feraccru®

(Ferric Maltol)

 

Feraccru®
Our lead product, Ferric Maltol, is approved for the treatment of iron deficiency by the FDA and marketed in the US as Accrufer®.

It is also approved by the EMAQ and Swiss Medic and is marketed as Feraccru® in the European Union by our commercial partner Norgine B.V.

For further information on Feraccru® please click here.